Logo - springer
Slogan - springer

Biomedical Sciences - Cancer Research | Cellular Oncology (Editorial Board)

Cellular Oncology

Cellular Oncology

The official journal of the International Society for Cellular Oncology

Editor-in-Chief: Ad G. van Kessel

ISSN: 2211-3428 (print version)
ISSN: 2211-3436 (electronic version)

Journal no. 13402


Ad Geurts van Kessel

Department of Human Genetics, Radboud University Nijmegen Medical Centre, Nijmegen Centre for Molecular Life Sciences, Geert Grooteplein zuid 10, Nijmegen 6525 GA, Netherlands

E-mail: cellularoncology@umcn.nl

Associate Editors:

Thomas Ried, National Cancer Institute, Bethesda, USA

Walter Giaretti, National Cancer Institute, Genoa, Italy

Peter Hamilton, The Queen's University of Belfast, Belfast, UK

Mario Hermsen, Hospital Universitario Central de Asturias, Oviedo, Spain

Begoňa Diosdado, VU University Medical Center, Amsterdam, The Netherlands

Jianping Wang, Sun Yat-sen University, Guangzhou, China

Britta Weigelt, Memorial Sloan Kettering Cancer Center, New York, USA 

Patrick  Derksen, University Medical Center Utrecht, Utrecht, The Netherlands

Editorial Board:

Donna G. Albertson, San Francisco, USA

Jan Baak, Stavanger, Norway

Nick Barker, Singapore, Singapore

Thomas Cremer, Munich, Germany

Paul van Diest, Utrecht, The Netherlands

Manon van Engeland, Maastricht, The Netherlands

Manel Esteller, Madrid, Spain

Yuval Garini, Ramat Gan, Israel

Michael Ghadimi, Göttingen, Germany

Giuseppe Giaconne, Bethesda, USA

Françoise Giroud, La Tonce Cedex, France

Heike Grabsch, Leeds, UK

Günther Haroske, Dresden, Germany

Hans Joenje, Amsterdam, The Netherlands

Olli-Pekka Kallioniemi, Turku, Finland

Calum MacAulay, Vancouver, Canada

Gerrit A. Meijer, Amsterdam, The Netherlands

K. Metze, Campinas, Brazil

Johan Offerhaus, Utrecht, The Netherlands

Athanasios Papavassiliou, Athens, Greece

Iver Petersen, Jena, Germany

Françoise Praz, Villejuif, France

Evelin Schröck, Dresden, Germany

Rosella Silvestrini, Milan, Italy

Hans Tanke, Leiden, The Netherlands

Patrick Tan, Singapore, Singapore

Bauke Ylstra, Amsterdam, The Netherlands




For authors and editors

  • Journal Citation Reports®, Thomson Reuters
    2013 Impact Factor
  • 2.124
  • Aims and Scope

    Aims and Scope


    As of 2011, Cellular Oncology will be publishing scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions. A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology will form a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologist and other clinicians involved in the management of cancer patients. Cellular Oncology publishes original papers, rapid communications, topical reviews, technical notes, special reports and letters.                     

    "In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations."

  • Submit Online
  • Open Choice - Your Way to Open Access
  • Instructions for authors
  • Author Academy: Training for Authors

Alerts for this journal


Get the table of contents of every new issue published in Cellular Oncology.